FDA Warning Letter — Bret R. Rutherford, M.D.

Case 670544 — FEI 3023259471

The FDA took a Warning Letter action against Bret R. Rutherford, M.D. on March 21, 2024 (New York, NY). The action was issued by CDER and concerns drugs products. This facility has 1 recent FDA inspection on record.

Action Details

Facility
Bret R. Rutherford, M.D.
Date
March 21, 2024
Fiscal Year
2024
Product Type
Drugs
Center
CDER
Location
New York, NY (United States)